focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 133.00
Bid: 130.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 6.00 (4.615%)
Open: 133.00
High: 133.00
Low: 133.00
Prev. Close: 133.00
NBS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tender Offer

28 Jun 2023 15:53

RNS Number : 2794E
Nationwide Building Society
28 June 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN (1) THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (THE UNITED STATES), (2) THE REPUBLIC OF ITALY, OR (3) ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

Nationwide Building Society announces results of

its Open Market Repurchase Exercise

in respect of its Core Capital Deferred Shares

28 June 2023.  On 20 February 2023, Nationwide Building Society (Nationwide) announced the launch of an open market repurchase facility (the OMR Facility) under which it may, from time to time and in its sole discretion, seek to repurchase limited numbers of the Core Capital Deferred Shares of £1 nominal amount each (ISIN: GB00BBQ33664) (the CCDS) issued by Nationwide. On 26 June 2023, Nationwide announced the commencement of the second open market repurchase exercise under the OMR Facility (the OMR Exercise 2023-2).

The OMR Exercise 2023-2 was made on the terms and subject to the conditions contained in the announcement made by Nationwide on 26 June 2023 (the Launch Announcement). Capitalised terms used, but not defined, in this announcement have the meanings given to them in the Launch Announcement.

The OMR Tender Period expired at 3.00 p.m. (London time) on 28 June 2023, and Nationwide announces today the results of the OMR Exercise 2023-2.

Results of OMR Exercise 2023-2

Nationwide announces that it has decided to set the OMR Acceptance Amount at 657,547 CCDS, and that Nationwide will accordingly accept for purchase CCDS validly tendered pursuant to the OMR Exercise 2023-2 subject to application of a Scaling Factor of 55.34 per cent., as described in the Launch Announcement.

The expected settlement date for CCDS validly tendered during the OMR Tender Period and accepted for purchase by Nationwide is 3 July 2023 (the Settlement Date).

On the Settlement Date, each Eligible Holders of CCDS validly tendered for purchase pursuant to the OMR Exercise 2023-2 and accepted for purchase will receive an amount (rounded down to the nearest £0.01, with half a penny rounded upwards) equal to the sum of (i) the Purchase Price of £114.06 per CCDS accepted for purchase from such Eligible Holder and (ii) an Amount Attributable to Potential Future Distributions of £0.36407104 per CCDS accepted for purchase from such Eligible Holder.

Nationwide intends to hold all CCDS purchased by it pursuant to the OMR Exercise 2023-2 in treasury, and future re-sales of any purchased CCDS may occur from time to time at the sole discretion of Nationwide. The Conditions of the CCDS provide that any such re-sale will not be subject to pre-emption rights.

Summary

Description of the CCDS

ISIN

OMR Acceptance Amount

Scaling Factor

Aggregate number of CCDS outstanding following the OMR Exercise 2023-2

Nationwide's Core Capital Deferred Shares of £1 nominal amount each

GB00BBQ33664

657,547 CCDS

55.34 per cent.

9,122,345*

* This figure excludes the CCDS purchased by Nationwide pursuant to the OMR Exercise 2023-2 or previously purchased by Nationwide and held in treasury, which (for so long as they are held by Nationwide in treasury) will be deemed not to be outstanding for certain purposes under the Conditions of the CCDS.

UBS AG London Branch (Telephone: +44 20 7568 1121; Attention: Liability Management Group; Email: ol-liabilitymanagement-eu@ubs.com) is acting as Dealer Manager in connection with the OMR Exercise 2023-2.

LEI of Nationwide Building Society: 549300XFX12G42QIKN82

DISCLAIMER

This announcement must be read together with the Launch Announcement. No offer or invitation to acquire any securities is being made pursuant to this announcement.

The distribution of this announcement and the Launch Announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Launch Announcement come(s) are required by Nationwide and the Dealer Manager to inform themselves about, and to observe, any such restrictions.

The OMR Exercise 2023-2 has now expired and no additional CCDS will be accepted for purchase pursuant to the OMR Exercise 2023-2.

This announcement is made by Nationwide, and the Dealer Manager does not accept any responsibility for the contents of this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TENKZGZVDRZGFZM
Date   Source Headline
8th Feb 20197:00 amRNSInterim Management Statement 31 December 2018
11th Jan 201911:31 amRNSPublication of Final Terms
20th Dec 20182:45 pmRNSPublication of Suppl.Prospcts
18th Dec 20183:29 pmRNSPublication of a Prospectus
28th Nov 20186:02 pmRNSNationwide's Response to the Stress Test Results
22nd Nov 20181:24 pmRNSPublication of Suppl.Prospcts
22nd Nov 20187:00 amRNSNationwide Building Society - Interim Results 2018
19th Nov 20184:34 pmRNSRedemption of PIBS
14th Nov 20189:25 amRNSPublication of Final Terms
13th Nov 20189:53 amRNSPublication of Final Terms
13th Nov 20189:51 amRNSPublication of Final Terms
7th Nov 201810:07 amRNSPublication of Final Terms
31st Oct 20184:11 pmRNSPublication of a Prospectus
29th Oct 201811:09 amRNSPublication of Final Terms
23rd Oct 20187:00 amRNSPublication of Final Terms
4th Oct 20182:38 pmRNSPublication of Final Terms
1st Oct 20181:11 pmRNSAmendments to the Transaction Documents
14th Sep 20187:00 amRNSRedefining service for a digital world
10th Aug 20187:00 amRNSInterim Management Statement 30 June 2018
31st Jul 20183:25 pmRNSPublication of Final Terms
19th Jul 20183:35 pmRNSResult of AGM
26th Jun 20184:24 pmRNSNationwide - Publication of a Base Prospectus
23rd May 20182:23 pmRNSPublication of Supplementary Prospectus
22nd May 20187:00 amRNSPreliminary Results Announcement 2017/18
4th May 20189:40 amRNSPost Stab Notice Nationwide BS FR Cov Bds 2023
13th Apr 20183:34 pmRNSPublication of Final Terms
9th Apr 201810:20 amRNSPost-Stabilisation Notice - Nationwide 8nc7 SNP
5th Apr 20188:33 amRNSPre-Stab Notice Nationwide Building SocietyGBP FRN
16th Mar 201810:24 amRNSNotice of Redemption of PIBS
9th Mar 201811:55 amRNSResults of Tender Offer
9th Mar 20189:12 amRNSIndicative Results of Tender Offer
8th Mar 20182:46 pmRNSResults of Tender Offer
7th Mar 20184:43 pmRNSAnnouncement of Pricing pursuant to Tender Offer
7th Mar 201812:38 pmRNSPublication of Final Terms
6th Mar 20185:10 pmRNSPublication of Final Terms
1st Mar 201810:55 amRNSPre-Stabilisation Notice - Nationwide
28th Feb 20183:14 pmRNSUS Tender Offer
28th Feb 20183:13 pmRNSNon-US Tender Offer
28th Feb 20187:00 amRNSModification to 2018 Notes
28th Feb 20187:00 amRNSModification to 2023 Notes
20th Feb 20182:58 pmRNSNoteholder Meeting Results
16th Feb 20182:54 pmRNSPublication of a Prospectus
9th Feb 20183:55 pmRNSPublication of Suppl.Prospcts
9th Feb 20187:00 amRNSInterim Management Statement
6th Feb 20187:00 amRNSConsent Solicitation Early Consent Deadline
25th Jan 20188:50 amRNSConsent Solicitation
19th Jan 201810:43 amRNSNotice of Redemption
20th Dec 20174:05 pmRNSPublication of a Prospectus
28th Nov 20177:15 amRNSNationwide's Response to the Stress Test Results
20th Nov 20174:29 pmRNSNationwide Building Society Half-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.